Implementation of a nurse-delivered intravitreal injection service

Eye (Basingstoke)

Volumn 28, Issue 6, 2014, Pages 734-740

  Dacosta, J ^a   Hamilton, R ^a   Nago, J ^a   Mapani, A ^a   Kennedy, E ^a   Luckett, T ^a   Pavesio, C ^a   Flanagan, D ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONJUNCTIVAL HEMORRHAGE; EXPERIENCE; HUMAN; INTRAVITREAL DRUG ADMINISTRATION; NURSE; PATIENT EXPERIENCE; PATIENT SAFETY; PATIENT SATISFACTION; RANK SUM TEST; RETINA; SUBCONJUNCTIVAL HEMORRHAGE;

EID: 84928756852     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2014.69     Document Type: Article

References (18)

1. NICE technology appraisal guidance 155; issued August 2008, modified May 2012.
2. Marshall GN, Hays RD. The patient satisfaction questionnaire short form (PSQ-18) 1994: RAND.
3. Augood CA, Vingerling JR, de Jong PT, Chakravarthy U, Seland J, Soubrane G et al. Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE). Arch Ophthalmol 2006; 124: 529-535.
4. Bunce C, Wormald R. Leading causes of certification for blindness and partial sight in England & Wales. BMC Public Health 2006; 6: 58.
5. Minassian DC, Reidy A, Lightstone A, Desai P. Modelling the prevalence of age-related macular degeneration (2010-2020) in the UK: expected impact of anti-vascular endothelial growth factor (VEGF) therapy. Br J Ophthalmol 2011; 95: 1433-1436.
6. Resnikoff S, Felch W, Gauthier T-M, Spivey B. The number of ophthalmologists in practice and training worldwide: a growing gap despite more than 200,000 practitioners. Br J Ophthalmol 2012; 96: 783-787.
7. College statement on intraocular injections by non medical health care professionals, April 2013. www.rcophth.ac.uk. (accessed 26 January 2014).
8. Royal College of Ophthalmology statement. Maximising capacity in AMD services, 1/12/09 www.rcophth.ac.uk. (accessed 29 January 2014).
9. Burns-Cox CJ. Shared care, past and future. Ophthalmic Physiol Opt 1995; 15(5): 379-381.
10. Department of Health. Shared care guidelines, Issued 2004.
11. Royal College of Ophthalmologists. Cataract surgery guidelines, Issued 2004.
12. Riad RF, Dart JK, Cooling RJ. Primary care and ophthalmology in the United Kingdom. Br J Ophthalmol 2003; 87(4): 493-499.
13. Department for Health. The NHS Plan: a plan for investment, a plan for reform, Issued 2000.
14. Nursing and Midwifery Council (NMC) 2008, Code of Professional conduct: Standards for conduct, performance and ethics. NCM, London.
15. The National Institute for Health and Clinical Excellence. Ranibizumab for treating diabetic macular oedema. NICE technology appraisal guidance 274, Issued 2013.
16. The National Institute for Health and Clinical Excellence. Ranibizumab for treating visual impairment caused by macular oedema secondary to retinal vein occlusion. NICE technology appraisal guidance 283, Issued 2013.
17. Lyall DAM, Tey A, Foot B, Roxburgh STD, Virdi M, Robertson C et al. Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors, and outcomes. Eye 2012; 26: 1517-1526.
18. Varma D, Lunt D, Johnson P, Stanley S. A novel approach to expanding the role of nurses to deliver intravitreal injections for patients with age related macular degeneration. Int J Ophthalm Pract 2013; 4(2): 68-74.